MarketsMOJO rates Abbott India Ltd as Sell
MarketsMOJO has issued a Sell rating for Abbott India Ltd, reflecting concerns about its stock performance. The rating, based on quality and financial assessments, suggests investors should consider reducing exposure or avoiding new purchases.
pre-market1 source ↓written by the desknot a recommendation
MarketsMOJO has assigned a Sell rating to Abbott India Ltd, indicating a cautious outlook for investors. This recommendation is based on an evaluation of quality, valuation, financial trends, and technicals. As of 12 May 2026, the rating reflects concerns about the stock's performance in the Pharmaceuticals sector.
• ROE at 32.5% suggests efficient capital use.
• Investors may want to reduce exposure or avoid new purchases.
Immediate implications may include increased selling pressure in the stock.
Not investment advice. For informational purposes only.